Market Cap (In USD)
140.14 Million
Revenue (In USD)
425.17 Million
Net Income (In USD)
-92.21 Million
Avg. Volume
687.01 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3.71-22.525
- PE
- -
- EPS
- -
- Beta Value
- 0.931
- ISIN
- US64157F1030
- CUSIP
- 64157F103
- CIK
- 1444380
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Kevin R. Thornal
- Employee Count
- -
- Website
- https://www.nevro.com
- Ipo Date
- 2014-11-06
- Details
- Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
More Stocks
-
NRL
-
ADMAADMA Biologics, Inc.
ADMA
-
GTBO
-
CYIENTDLMCyient DLM Limited
CYIENTDLM
-
TAJGVK
-
COMSYNCommercial Syn Bags Limited
COMSYN
-
PUBGYPublicis Groupe S.A.
PUBGY
-
9663